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Summary 36 
As the proportion of foreign-born persons among tuberculosis (TB) notifications continues to rise, 37 
Japan is preparing to introduce pre-migration TB screening for those coming from selected countries, 38 
who are intending to stay for more than 90 days. It has announced that the programme will commence 39 
in 2020. In this review, the authors examine the experiences from two countries which already have 40 
years of experience in operating pre-migration TB screening, namely the United Kingdom and 41 
Australia.  The authors point out that both countries have developed strong health information system 42 
to not only to collect and analyze screening results, but also to use the data to effectively monitor and 43 
evaluate the screening program itself.  The critical role which health information system plays within 44 
pre-migration screening is often overlooked, however that the authors argue that Japan, as with any 45 
other countries planning to introduce pre-migration screening for TB, must also plan for data 46 
management.  47 
 48 
Introduction 49 
It has for some time been recognized that migrants from high tuberculosis (TB) incidence countries 50 
are at a higher risk for getting TB. In addition, there is also a risk of TB treatment interruption in some 51 
cohorts.1 ,2 ,3 Moreover, changing patterns of migration have resulted in an increasing proportional 52 
contribution of TB cases among foreign-born persons in a number of countries, including both low- 53 
and middle-TB burden countries4,5,6. Pre-entry TB screening has become increasingly popular as one 54 
of the strategies to address this, and has been introduced, mainly in high-income countries such as 55 
Arab States of the Gulf, Australia, some European states, New Zealand, and North America. As 56 
evidence for effectiveness and cost-effectiveness of pre-entry TB screening builds up7 , 8 ,9 , more 57 
countries are considering pre-entry TB screening programmes as a possible policy option. Japan is one 58 
such country, as it prepares to introduce pre-entry TB screening for its incoming foreign-born persons 59 
in 2020. In this paper, the authors wish to send out the message that “the first step is always the hardest” 60 
– and point to potential pitfalls if the start of such a program is rushed, with a specific emphasis on the 61 
importance of an effective health information system to support the program. 62 
 63 
Background to Japan’s introducing pre-migration TB screening 64 
In Japan, the annual TB notification rate has fallen to 12.3 per 100,000 population in 2018, and is 65 
steadily approaching the national target of 10 per 100,000 by 202010. Conversely, both the number and 66 
proportion of foreign-born TB patients of all notifications has been increasing for the past decade, 67 
from 945 in 2008 to 1,667 in 2018, contributing to 10.7% out of total notifications.  Moreover, the 68 
proportion is as high as 70.8% among those aged between 15 and 24 years old2,7. About 80% of 69 
foreign-born TB patients in Japan were born in six countries, the Philippines, China, Vietnam, 70 
Indonesia, Nepal, and Myanmar 2,7. In response to the growing burden of foreign-born TB patients in 71 
Japan, the Ministry of Health, Labor, and Welfare (MOHLW) of Japan has announced in February 72 
2018 its decision to introduce a pre-entry TB screening ahead of the Tokyo Olympics Games in 2020. 73 
Its programme is targeted towards all visa applicants who wish to stay in Japan for more than 90 days 74 
from the above six countries, and aims to screen for active TB. In preparing for the screening 75 
programme, it is tempting to focus on perfecting the screening algorithm itself, particularly when the 76 
working group consists largely of TB physicians. However, whilst this is important, a pre-entry TB 77 
screening programme is more than a practice of screening for an infectious disease. It is a national 78 
project crossing multiple sectors and agencies, with different interests and required outcomes in 79 
respect of visa grants and border entry that are not necessarily always aligned with the spirit of public 80 
health to assist individual and broader community health. It is an ongoing operation that must be 81 
justifiable, based on rigorous continuous evaluation mechanism. In order for such evaluation to take 82 
place, data must be collected and analyzed. In other word, a strong health information system should 83 
be an integral component of the pre-entry TB screening programme. We now turn to the experiences 84 
of the United Kingdom (UK) and Australia to highlight our point on accurate and meaningful data 85 
capture to allow through analysis of programmes. 86 
 87 
UK and the UKTB 88 
Based on a successful pilot in eight countries between 2005 and 2011, the UK rolled out pre-entry 89 
screening for TB between 2012 and 2014. The programme requires persons who apply for a visa to 90 
enter the UK for longer than six months and who come from countries with a TB incidence of 40 per 91 
100,000 or above to be certified free of TB. Screening for TB is carried out through symptom check 92 
and chest X-ray (CXR), followed by three sputum smears and cultures, in the event of abnormality of 93 
initial screening. Confirmed TB patients are offered treatment in the country of origin, i.e., before re-94 
screening and clearance. Screening is carried out by a panel consisting of locally qualified physicians, 95 
radiologists, and TB laboratories designated by the UK authorities and informed by the UK Technical 96 
Instructions11. As of November 2019, screening is operational globally in 101 countries with more 97 
than 140 panel clinics12. 98 
 99 
Screening data is collected by the panel clinics and collated and analyzed by the Public Health England 100 
(PHE). Whilst most providers utilize a structured data submission template designed by the PHE, 101 
about 40% of panel clinics, which are managed by the International Organization for Migration (IOM) 102 
utilize a bespoke IOM global clinical management system called the UKTB, which feeds into the PHE 103 
monitoring and surveillance system. UKTB consolidates data from all IOM locations in a central 104 
online database and provides information for monitoring of trends and epidemiological situation in 105 
the processing locations. It has been reported that while IOM data is of good quality, non-IOM data 106 
can often contain missing variables and discrepant dates13. Whenever possible, missing values are 107 
deduced from other variables. Both structured data submissions from non-IOM clinics and IOM data 108 
from UKTB are then consolidated in the PHE into a common dataset, which is reported on and used 109 
for surveillance, monitoring and quality assurance, as well as to inform about effectiveness and cost-110 
effectiveness of the screening.  According to the latest PHE annual report12, 304,234 applicants were 111 
screened in 2018. A total of 318 TB cases were detected, giving an overall TB yield of 104.5 per 112 
100,000 applicants. 113 
 114 
Australia and the eMedical 115 
Australia has had a pre-entry health screening programme (initially undertaken on ships before arrival) 116 
since the introduction of the Immigration (Restriction) Act at the time of federation in 190114. Today, 117 
all visa applicants must be free from TB, mostly through self-declaration although under the current 118 
health assessment programme, Australia physically screens over 750,000 migrants annually for TB, 119 
including all permanent migrants and humanitarian entrants, and all visa applicants intending to stay 120 
in Australia15 for a period of longer than 6 months where they come from a country with TB incidence 121 
of greater than 40 per 100,000 or are health care workers. TB screening similarly consists of a 122 
comprehensive physical examination for all, including CXR for those 11 years and older. For children 123 
aged 2–10 years, to minimise the number of x-ray exposures in this age group, they are primarily 124 
screened with a latent TB infection (LTBI) test (either Interferon Gamma Release Assay, IGRA or 125 
Tuberculin Skin Test, TST). Those suspected of TB follow a similar algorithm to the UK. Health 126 
assessment and screening for TB is conducted by panels according to Australian -specified guidelines16. 127 
Such panels currently operate in 167 countries through approximately 600 clinics including over 40 128 
designated TB centres. While newer molecular technologies such as XpertMTB/RIF have been 129 
considered and are used in positive smears for earlier treatment decisions, the use of culture is still felt 130 
to provide higher yield and assurance and hence are still seen as essential in this process. 131 
 132 
Panel physicians for Australia must use an electronic medical system, eMedical, to enter the health 133 
assessment and subsequent results and management of TB. It is a web-based, user-friendly application 134 
that is directly linked to the visa application process, and as with UKTB, plays an integral part in 135 
producing data with which to evaluate Australia’s screening program. Furthermore, aside from 136 
managing clinical information for pre-entry TB screening, one distinct feature of eMedical is that it is 137 
also available through a password protected process for TB specialists within Australia. Australia 138 
requires applicants with previously treated TB17 , or LTBI (abnormal CXR finding consistent with 139 
previous TB or positive LTBI test) to attend within 28 days of arrival – through eMedical, TB 140 
physicians who can access information on such applicants, and conduct the necessary follow-up. Their 141 
visa status is dependent on attending for this further TB follow-up, which might require 2 to 3 years 142 
monitoring in some cases.  This system is used to analyse the data from all countries to compare to 143 
WHO incident rates as well as the post-arrival notifications from the same countries. This allows 144 
identification of potential areas of under-diagnosis premigration and specific actions that can then be 145 
used to address any shortcomings as identified in the pooled data example in the next paragraph. 146 
 147 
A second distinct feature of eMedical is that it is shared by Canada, New Zealand, and US. Through 148 
such a system there is much data and information that can be gained through sharing and building on 149 
a common database. This includes testing and comparing screening algorithms and diagnostic tests, 150 
comparing migrant cohorts at greater risk, the quality of the reporting and performance and panel 151 
physicians. One such project that was looked at collectively by these countries was the very low yield 152 
rates in the premigration health assessment phase that all were receiving from one large and significant 153 
sending country with very high incidence of TB and high rates of TB post arrival in migrants from this 154 
country. The yield rates were less than 90% of the reported incidence in the country, atypical of active 155 
screening seen for other countries who usually have the same or higher incidence in many 156 
circumstances. By pooling data, the five countries were able to target specific initiatives to further 157 
clarify weaknesses in the programme and address improved screening practice such as TB laboratory 158 
processes, analysis of cohort of migrants, review of integrity measures and the role of migration agents 159 
and ‘pre-treatment’ for TB. 160 
 161 
Concluding remarks: so, what are the lessons for Japan? 162 
Surprisingly most countries do not have in place health information systems to assist in the tracking 163 
and monitoring of TB outcomes from their premigration screening programmes and as such require 164 
significant handling of at times, inaccurate manual data collection systems. The experiences from the 165 
two countries clearly highlight the importance of establishing a good health information system at the 166 
outset of any screening programme through which data can be collected, collated, analyzed, and 167 
reported. Such information is necessary not only to produce indicators with which to evaluate the 168 
programme, but can also assist to identify quality issues, point out to specific groups who may require 169 
particular attention and – as in the case of Australia, link pre-migration screening electronically to 170 
post-entry health care. The pattern of migration, and with it the priorities for pre-migration screening, 171 
are constantly in a flux and the health information is critical in allowing the program to be responsive 172 
and fine-tune itself.  173 
 174 
Lastly, pre-migration screening is not simply about detecting TB among migrants who are intending 175 
to travel – it is about improving and sustaining the welfare and health of migrant population, and pre-176 
migration screening must be able to contribute to that ultimate objective. Without the health 177 
information system, there will be no data. And without data, it will be impossible to assess whether or 178 
not the screening programme is achieving what is it supposed to achieve.  179 
 180 
Japan now stands at a crossroads between initiating its pre-entry TB screening quickly and with 181 
minimum investment into health information system, and spending some considerable time and effort 182 
in preparing for electronic data collection and analysis.  The experiences from the two countries, UK 183 
and Australia, however clearly seem to indicate that while it is undoubtedly true that the start is always 184 
the hardest, a good and right beginning almost always assures success.  Let us hope that Japan is 185 
convinced that this is so, and makes that start. 186 
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